117 related articles for article (PubMed ID: 38321884)
1. Selective expansion of renal cancer stem cells using microfluidic single-cell culture arrays for anticancer drug testing.
Wang X; He T; Chen Z; Chen J; Luo Y; Lin D; Li X; Liu D
Lab Chip; 2024 Mar; 24(6):1702-1714. PubMed ID: 38321884
[TBL] [Abstract][Full Text] [Related]
2. Gel-Free Single-Cell Culture Arrays on a Microfluidic Chip for Highly Efficient Expansion and Recovery of Colon Cancer Stem Cells.
Liu Y; Chen X; Chen J; Luo Y; Chen Z; Lin D; Zhang J; Liu D
ACS Biomater Sci Eng; 2022 Aug; 8(8):3623-3632. PubMed ID: 35786837
[TBL] [Abstract][Full Text] [Related]
3. Three-Dimensional Cell Culture Model Utilization in Renal Carcinoma Cancer Stem Cell Research.
Maliszewska-Olejniczak K; Brodaczewska KK; Bielecka ZF; Czarnecka AM
Methods Mol Biol; 2018; 1817():47-66. PubMed ID: 29959702
[TBL] [Abstract][Full Text] [Related]
4. Microgel Single-Cell Culture Arrays on a Microfluidic Chip for Selective Expansion and Recovery of Colorectal Cancer Stem Cells.
Lin D; Chen X; Liu Y; Lin Z; Luo Y; Fu M; Yang N; Liu D; Cao J
Anal Chem; 2021 Sep; 93(37):12628-12638. PubMed ID: 34495647
[TBL] [Abstract][Full Text] [Related]
5. Screening Therapeutic Agents Specific to Breast Cancer Stem Cells Using a Microfluidic Single-Cell Clone-Forming Inhibition Assay.
Lin D; Li P; Feng J; Lin Z; Chen X; Yang N; Wang L; Liu D
Small; 2020 Mar; 16(9):e1901001. PubMed ID: 30998296
[TBL] [Abstract][Full Text] [Related]
6. Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer.
Ge Y; Weygant N; Qu D; May R; Berry WL; Yao J; Chandrakesan P; Zheng W; Zhao L; Zhao KL; Drake M; Vega KJ; Bronze MS; Tomasek JJ; An G; Houchen CW
Int J Cancer; 2018 Sep; 143(5):1162-1175. PubMed ID: 29577277
[TBL] [Abstract][Full Text] [Related]
7. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase inhibitors target cancer stem cells in renal cell cancer.
Czarnecka AM; Solarek W; Kornakiewicz A; Szczylik C
Oncol Rep; 2016 Mar; 35(3):1433-42. PubMed ID: 26708631
[TBL] [Abstract][Full Text] [Related]
9. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
[TBL] [Abstract][Full Text] [Related]
10. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
Wang L; Park P; La Marca F; Than KD; Lin CY
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
[TBL] [Abstract][Full Text] [Related]
11. Metastatic renal cell carcinoma cells growing in 3D on poly‑D‑lysine or laminin present a stem‑like phenotype and drug resistance.
Brodaczewska KK; Bielecka ZF; Maliszewska-Olejniczak K; Szczylik C; Porta C; Bartnik E; Czarnecka AM
Oncol Rep; 2019 Nov; 42(5):1878-1892. PubMed ID: 31545459
[TBL] [Abstract][Full Text] [Related]
12. Selective Single-Cell Expansion on a Microfluidic Chip for Studying Heterogeneity of Glioma Stem Cells.
Li P; Qin Z; Zhong Y; Kang H; Zhang Z; Hu Y; Wen L; Wang L
Anal Chem; 2022 Feb; 94(7):3245-3253. PubMed ID: 35148070
[TBL] [Abstract][Full Text] [Related]
13. Triiodothyronine regulates cell growth and survival in renal cell cancer.
Czarnecka AM; Matak D; Szymanski L; Czarnecka KH; Lewicki S; Zdanowski R; Brzezianska-Lasota E; Szczylik C
Int J Oncol; 2016 Oct; 49(4):1666-78. PubMed ID: 27632932
[TBL] [Abstract][Full Text] [Related]
14. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
[TBL] [Abstract][Full Text] [Related]
15. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
[TBL] [Abstract][Full Text] [Related]
16. Acquired resistance to sunitinib in human renal cell carcinoma cells is mediated by constitutive activation of signal transduction pathways associated with tumour cell proliferation.
Sakai I; Miyake H; Fujisawa M
BJU Int; 2013 Jul; 112(2):E211-20. PubMed ID: 23305097
[TBL] [Abstract][Full Text] [Related]
17. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of a combination of interferon-alpha and sorafenib on human renal carcinoma cell lines.
Tochizawa S; Masumori N; Yanai Y; Ohmoto Y; Yabuuchi Y; Tsukamoto T
Biomed Res; 2008 Dec; 29(6):271-8. PubMed ID: 19129670
[TBL] [Abstract][Full Text] [Related]
19. Parthenolide inhibits the tumor characteristics of renal cell carcinoma.
Liu D; Han Y; Liu L; Ren X; Zhang H; Fan S; Qin T; Li L
Int J Oncol; 2021 Jan; 58(1):100-110. PubMed ID: 33367934
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment.
Callero MA; Suárez GV; Luzzani G; Itkin B; Nguyen B; Loaiza-Perez AI
Int J Oncol; 2012 Jul; 41(1):125-34. PubMed ID: 22485252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
